Back to Search Start Over

Clinical application of genomic high-throughput data: Infrastructural, ethical, legal and psychosocial aspects.

Authors :
Umbach N
Beißbarth T
Bleckmann A
Duttge G
Flatau L
König A
Kuhn J
Perera-Bel J
Roschauer J
Schulze TG
Schweda M
Urban A
Zimmermann A
Sax U
Source :
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2020 Feb; Vol. 31, pp. 1-15. Date of Electronic Publication: 2019 Dec 20.
Publication Year :
2020

Abstract

Genomic high-throughput technologies (GHTT) such as next-generation sequencing represent a fast and cost-effective tool toward a more comprehensive understanding of the molecular background of complex diseases. However, technological advances contrast with insufficient application in clinical practice. Thus, patients, physicians, and other professionals are faced with tough challenges that forestall the efficient and effective implementation. With the increasing application of genetic testing, it is of paramount importance that physicians and other professionals in healthcare recognize the restrictions and potential of GHTT, in order to understand and interpret the complex data in the context of health and disease. At the same time, the growing volume and complexity of data is forever increasing the need for sustainable infrastructure and state-of-the-art tools for efficient data management, including their analysis and integration. The large pool of sensitive information remains difficult to interpret and fundamental questions spanning from billing to legal, social, and ethical issues have still not been resolved. Here we summarize and discuss these obstacles in an interdisciplinary context and suggest ways to overcome them. Continuous discussion with clinicians, data managers, biostatisticians, systems medicine experts, ethicists, legal scholars, and patients illuminates the strengths, weakness, and current practices in the pipeline from biomaterial to sequencing and data management. This discussion also highlights the new, cross-disciplinary working collaborations to realize the wide-ranging challenges in clinical genomics including the exceptional demands placed on the staff preparing and presenting the data, as well as the question as to how to report the data and results to patients.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no competing interests.<br /> (Copyright © 2019. Published by Elsevier B.V.)

Details

Language :
English
ISSN :
1873-7862
Volume :
31
Database :
MEDLINE
Journal :
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Publication Type :
Academic Journal
Accession number :
31866110
Full Text :
https://doi.org/10.1016/j.euroneuro.2019.09.008